Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Historical Holders from Q4 2015 to Q3 2025

Symbol
WVE on Nasdaq
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
190M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
144M
Holdings value
$1.05B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
187
Number of buys
92
Number of sells
-79
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 13.4% -8% $170M 25.5M 0% RA Capital Management, L.P. 11 Dec 2025
Adage Capital Management, L.P. 9.65% +18.8% $116M $19.3M 15M +20% Adage Capital Management, L.P. 30 Jun 2025
BlackRock, Inc. 6.1% $63.6M 9.36M BlackRock, Inc. 31 Dec 2024
MAVERICK CAPITAL LTD 5.4% $56.1M 8.26M Maverick Capital, Ltd. 31 Dec 2024

Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 144M $1.05B +$37.2M $7.32 187
2025 Q2 139M $903M +$46.4M $6.50 174
2025 Q1 131M $1.06B +$20.3M $8.08 192
2024 Q4 129M $1.59B +$86.6M $12.37 181
2024 Q3 120M $986M +$176M $8.20 160
2024 Q2 95.1M $474M +$9.85M $4.99 143
2024 Q1 92.8M $572M +$4.03M $6.17 131
2023 Q4 92.5M $468M +$93.1M $5.05 115
2023 Q3 72.6M $417M +$3.01M $5.75 85
2023 Q2 72.1M $263M +$6.43M $3.64 80
2023 Q1 70.1M $303M +$3.78M $4.33 72
2022 Q4 68.1M $477M +$7.42M $7.00 74
2022 Q3 67.3M $243M -$1.61M $3.61 58
2022 Q2 67.8M $220M +$69.1M $3.25 56
2022 Q1 47.6M $95.1M -$1.04M $2.00 77
2021 Q4 47.3M $148M +$13.3M $3.14 87
2021 Q3 37.4M $184M +$444K $4.90 84
2021 Q2 37M $247M -$5.85M $6.66 82
2021 Q1 38.3M $215M +$1.5M $5.61 97
2020 Q4 36.1M $284M -$9.57M $7.87 102
2020 Q3 37.1M $316M +$59.3M $8.49 106
2020 Q2 29.4M $306M -$6.71M $10.41 89
2020 Q1 30.1M $282M +$9.44M $9.37 76
2019 Q4 29.5M $236M -$44.4M $8.01 87
2019 Q3 30.9M $634M +$1.03M $20.53 86
2019 Q2 30.5M $794M +$39.6M $26.09 100
2019 Q1 29.4M $1.14B +$192M $38.85 109
2018 Q4 24.4M $1.03B +$23.1M $42.04 91
2018 Q3 23.8M $1.19B -$29.7M $50.00 92
2018 Q2 24.5M $936M +$30.3M $38.25 77
2018 Q1 23.7M $949M +$61.1M $40.10 79
2017 Q4 22.2M $780M +$59.9M $35.10 72
2017 Q3 20.5M $446M +$26.5M $21.75 58
2017 Q2 19.3M $359M +$67M $18.60 55
2017 Q1 15.7M $432M +$32.8M $27.50 49
2016 Q4 14.8M $388M +$18.2M $26.15 51
2016 Q3 14.1M $457M -$3.4M $32.47 45
2016 Q2 14.2M $294M +$6.8M $20.69 37
2016 Q1 14M $192M +$2.93M $13.88 22
2015 Q4 13.8M $219M +$196M $15.95 18